-
Study aim
-
The study's aim is to assess the rate of improvement in gastrointestinal and non-gastrointestinal symptoms in achalasia patients receiving both balloon dilatation and botox injection concurrently, compared to balloon dilation alone, in order to understand patients' reasons for visits, gastrointestinal complications, endoscopy indications, and determine the most effective treatment approach.
-
Design
-
The present study is a clinical trial with a historical control group. The intervention group is selected from international patients with a diagnosis of esophageal achalasia in need of treatment For this group, balloon expansion is done with botox injection.
-
Settings and conduct
-
The present study is a clinical trial. The intervention group will be selected from patients diagnosed with esophageal achalasia in need of treatment, who are referred to the endoscopy depatement. For this group, balloon dilatation was performed simultaneously with botox injection.
-
Participants/Inclusion and exclusion criteria
-
Patients diagnosed with esophageal achalasia and aged 3 months to 14 years presenting with symptoms of dysphagia, weight loss, respiratory symptoms, and chest pain due to food aspiration, and exhibiting signs of FTT, abdominal pain, chest pain, or dental caries.
Patients who underwent balloon dilation for reasons other than achalasia, such as anastomotic stricture following esophageal atresia, syndromic FTTs, abdominal pain from alternative etiologies, and chest pain attributable to cardiac conditions
-
Intervention groups
-
patients diagnosed with esophageal achalasia in need of treatment, who were referred to the endoscopy department of Mofid Children's Hospital. For this group, balloon dilatation was performed simultaneously with botox injection.
-
Main outcome variables
-
changes in clinical symptoms and sign